BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 12, 2004
View Archived Issues
Expansion of Seattle Genetics/Genentech ADC collaboration
Read More
Pharmacopeia delivers development candidate in Organon collaboration
Read More
Ono and Merck & Co. in licensing agreements
Read More
Genentech and Rinat Neuroscience to codevelop and commercialize RI-624
Read More
Neurocrine Biosciences enters Parkinson's licensing agreement with Almirall
Read More
Peregrine and NABTT collaborate on Cotara study
Read More
Disappointing preliminary results of Trabio study
Read More
Orphan drug status for intravenous terlipressin for type 1 hepatorenal syndrome
Read More
New treatment for Alzheimer's disease claimed by Ares
Read More
Formulations for nasal delivery of loratadine described by Ranbaxy
Read More
Ranbaxy claims new lamotrigine formulations for epilepsy
Read More
A series of cytidine nucleoside analogues described in patent literature
Read More
Protein kinase modulators claimed by Sugen
Read More
Two series of CFR1 receptor antagonists disclosed
Read More
Cell Therapeutics researchers claim anticancer compounds
Read More
PYM-50018 awarded fast track status for ALS
Read More
Dusa and NCI to evaluate Levulan for oral cavity dysplasia
Read More
Novartis selects Vertex collaboration drug candidate for clinical development
Read More
Immtech completes African sleeping sickness study of DB-289
Read More
New data on the pharmacokinetics and antifungal effects of BAL-4815 and BAL-8557
Read More
Final phase II data on the antiviral efficacy of ANA-380 in HBV infection
Read More
A phase I/II trial confirms the efficacy and safety of NM-283 in hepatitis C
Read More
Valtorcitabine reported safe and effective in chronic hepatitis B
Read More
Novel DpT analogues show potent and selective antitumor activity
Read More
Cardioprotective effects of IAA-94 against doxorubicin-induced contractile dysfunction and apoptosis
Read More
Perlecan-inducing stent coating reduces intimal hyperplasia
Read More
Novel anticoccidial agent from Romark
Read More
Dual targeting of gyrase and topisomerase IV effective against Gram-positive and -negative pathogens
Read More
DNA polymerase III holoenzyme inhibitors with potent bactericidal activity
Read More
Novel polymerase target for HCV therapy
Read More
Merck selects integrin alphavbeta3 antagonist for development for osteoporosis
Read More